Positive inotropy of calcitonin gene-related peptide and amylin on porcine isolated myocardium

European Journal of Pharmacology

Volumn 385, Issue 2-3, 1999, Pages 147-154

  Saetrum Opgaard, Ole ^a,b   De Vries, René ^a   Tom, Beril ^a   Edvinsson, Lars ^b   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

(CGRP) Calcitonin gene related peptide; Adrenomedullin; Amylin; Inotropic effect; Myocardial contractility

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37];

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY;

EID: 0032786726     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00721-9     Document Type: Article

References (55)

1. Aiyar N., Rand K., Elshourbagy N.A., Zeng Z., Adamou J.E., Bergsma D.J., Li Y. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J. Biol. Chem. 271:1996;11325-11329.
2. Amara S.G., Jonas V., Rosenfeld M.G., Ong E.S., Evans R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 298:1982;240-244.
3. Amara S.G., Arriza J.L., Leff S.E., Swanson L.W., Evans R.M., Rosenfeld M.G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science. 229:1985;1094-1097.
4. Bell D., McDermott B.J. Calcitonin gene-related peptide stimulates a positive contractile response in rat ventricular cardiomyocytes. J. Cardiovasc. Pharmacol. 23:1994;1011-1021.
5. 1-preferring receptors coupled to positive contractile response in rat ventricular cardiomyocytes. Regul. Pept. 60:1995;125-133.
6. Bell D., Schluter K.D., Zhou X.J., McDermott B.J., Piper H.M. Hypertrophic effects of calcitonin gene-related peptide (CGRP) and amylin on adult mammalian ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 27:1995;2433-2443.
7. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukase M., Noda T., Fujita T. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 256:1989;E331-E335.
8. Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. U.S.A. 84:1987;8628-8632.
9. Dennis T., Fournier A., St Pierre S., Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J. Pharmacol. Exp. Ther. 251:1989;718-725.
10. Dennis T., Fournier A., Guard S., St Pierre S., Quirion R. Calcitonin gene-related peptide (hCGRP alpha) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences. Brain Res. 539:1991;59-66.
11. Du X.Y., Schoemaker R.G., Bos E., Saxena P.R. Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur. J. Pharmacol. 259:1994;173-180.
12. Ferrari R., Panzali A.F., Poole-Wilson P.A., Anand I.S. Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure. Lancet. 338:1991;1084.
13. Ferrier G.J., Pierson A.M., Jones P.M., Bloom S.R., Girgis S.I., Legon S. Expression of the rat amylin (IAPP/DAP) gene. J. Mol. Endocrinol. 3:1989;R1-R4.
14. Franco-Cereceda A., Bengtsson L., Lundberg J.M. Inotropic effects of calcitonin gene-related peptide, vasoactive intestinal polypeptide and somatostatin on the human right atrium in vitro. Eur. J. Pharmacol. 134:1987;69-76.
15. Franco-Cereceda A., Gennari C., Nami R., Agnusdei D., Pernow J., Lundberg J.M., Fischer J.A. Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ. Res. 60:1987;393-397.
16. Franco-Cereceda A., Henke H., Lundberg J.M., Petermann J.B., Hokfelt T., Fischer J.A. Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides. 8:1987;399-410.
17. Gennari C., Fischer J.A. Cardiovascular action of calcitonin gene-related peptide in humans. Calcif. Tissue Int. 37:1985;581-584.
18. Gennari C., Nami R., Agnusdei D., Fischer J.A. Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure. Cardiovasc. Res. 24:1990;239-241.
19. Giuliani S., Wimalawansa S.J., Maggi C.A. Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations. Br. J. Pharmacol. 107:1992;510-514.
20. Gulbenkian S., Saetrum Opgaard O., Ekman R., Costa Andrade N., Wharton J., Polak J.M., Queiroz e Melo J., Edvinsson L. Peptidergic innervation of human epicardial coronary arteries. Circ. Res. 73:1993;579-588.
21. Ikenouchi H., Kangawa K., Matsuo H., Hirata Y. Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation. 95:1997;2318-2324.
22. Ishikawa T., Okamura N., Saito A., Goto K. Effects of calcitonin gene-related peptide (CGRP) and isoproterenol on the contractility and adenylate cyclase activity in the rat heart. J. Mol. Cell. Cardiol. 19:1987;723-727.
23. Jougasaki M., Wei C.M., Heublein D.M., Sandberg S.M., Burtnett J.C. Jr. Immunohistochemical localization of adrenomedullin in canine heart and aorta. Peptides. 16:1995;773-775.
24. Jougasaki M., Wei C.M., McKinley L.J., Burnett J.C. Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 92:1995;286-289.
25. Jougasaki M., Rodeheffer R.J., Redfield M.M., Yamamoto K., Wei C.M., McKinley L.J., Burnett J.C. Jr. Cardiac secretion of adrenomedullin in human heart failure. J. Clin. Invest. 97:1996;2370-2376.
26. Kato J., Kitamura K., Kangawa K., Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur. J. Pharmacol. 289:1995;383-385.
27. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
28. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
29. Morris H.R., Panico M., Etienne T., Tippins J., Girgis S.I., MacIntyre I. Isolation and characterization of human calcitonin gene-related peptide. Nature. 308:1984;746-748.
30. Muff R., Born W., Fischer J.A. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur. J. Endocrinol. 133:1995;17-20.
31. Nakamura K., Toda H., Terasako K., Kakuyama M., Hatano Y., Mori K., Kangawa K. Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn. J. Pharmacol. 67:1995;259-262.
32. Nishikimi T., Saito Y., Kitamura K., Ishimitsu T., Eto T., Kangawa K., Matsuo H., Omae T., Matsuoka H. Increased plasma levels of adrenomedullin in patients with heart failure. J. Am. Coll. Cardiol. 26:1995;1424-1431.
33. Nishikimi T., Horio T., Sasaki T., Yoshihara F., Takishita S., Miyata A., Matsuo H., Kangawa K. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 30:1997;1369-1375.
34. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A., Bloom S.R. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
35. Parkes D.G. Cardiovascular actions of adrenomedullin in conscious sheep. Am. J. Physiol. 268:1995;H2574-H2578.
36. Parkes D.G., May C.N. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br. J. Pharmacol. 120:1997;1179-1185.
37. Porter T.R., Eckberg D.L., Fritsch J.M., Rea R.F., Beightol L.A., Schmedtje J.F. Jr., Mohanty P.K. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J. Clin. Invest. 85:1990;1362-1371.
38. Poyner D.R. Molecular pharmacology of receptors for calcitonin-gene-related peptide, amylin and adrenomedullin. Biochem. Soc. Trans. 25:1997;1032-1036.
39. Raddino R., Pela G., Manca C., Barbagallo M., D'Aloia A., Passeri M., Visioli O. Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J. Cardiovasc. Pharmacol. 29:1997;463-470.
40. Rademaker M.T., Charles C.J., Lewis L.K., Yandle T.G., Cooper G.J., Coy D.H., Richards A.M., Nicholls M.G. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation. 96:1997;1983-1990.
41. Rigel D.F., Grupp I.L., Balasubramaniam A., Grupp G. Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles. Am. J. Physiol. 257:1989;H1082-H1087.
42. Rubino A., Burnstock G. Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc. Res. 31:1996;467-479.
43. Saetrum Opgaard O., Gulbenkian S., Bergdahl A., Barroso C.P., Andrade N.C., Polak J.M., Queiroz e Melo J.Q., Edvinsson L. Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility. Cardiovasc. Res. 29:1995;463-468.
44. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:1993;921-927.
45. Sakata J., Shimokubo T., Kitamura K., Nishizono M., Iehiki Y., Kangawa K., Matsuo H., Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352:1994;105-108.
46. Sigrist S., Franco-Cereceda A., Muff R., Henke H., Lundberg J.M., Fischer J.A. Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology. 119:1986;381-389.
47. Szokodi I., Kinnunen P., Ruskoaho H. Inotropic effect of adrenomedullin in the isolated perfused rat heart. Acta Physiol. Scand. 156:1996;151-152.
48. Szokodi I., Kinnunen P., Tavi P., Weckstrom M., Toth M., Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation. 97:1998;1062-1070.
49. Van Gelderen E.M., Du X.Y., Schoemaker R.G., Saxena P.R. Carotid blood flow distribution, haemodynamics and inotropic responses following calcitonin gene-related peptide in the pig. Eur. J. Pharmacol. 284:1995;51-60.
50. Van Rossum D., Menard D.P., Fournier A., St-Pierre S., Quirion R. Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues. J. Pharmacol. Exp. Ther. 269:1994;846-853.
51. Westermark P., Wernstedt C., Wilander E., Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem. Biophys. Res. Commun. 140:1986;827-831.
52. Westfall T.C., Curfman-Falvey M. Amylin-induced relaxation of the perfused mesenteric arterial bed: meditation by calcitonin gene-related peptide receptors. J. Cardiovasc. Pharmacol. 26:1995;932-936.
53. Wharton J., Gulbenkian S. Peptides in the mammalian cardiovascular system. Experientia Suppl. 56:1989;292-316.
54. Wimalawansa S.J. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology and therapeutic potentials. Endocr. Rev. 17:1996;533-585.
55. Zimmermann U., Fischer J.A., Frei K., Fischer A.H., Reinscheid R.K., Muff R. Identification of adrenomedullin receptors in cultured rat astrocytes and in neuroblastboma x glioma hybrid cells (NG108-15). Brain Res. 724:1996;238-245.